아이슬란드 -
아이슬란드어 -
LYFJASTOFNUN (Icelandic Medicines Agency)
inegy tafla 10/80 mg
n.v. organon* - simvastatinum inn; ezetimibum inn - tafla - 10/80 mg
아이슬란드 -
아이슬란드어 -
LYFJASTOFNUN (Icelandic Medicines Agency)
simvastatin actavis filmuhúðuð tafla 20 mg
actavis group ptc ehf. - simvastatinum inn - filmuhúðuð tafla - 20 mg
아이슬란드 -
아이슬란드어 -
LYFJASTOFNUN (Icelandic Medicines Agency)
simvastatin actavis filmuhúðuð tafla 40 mg
actavis group ptc ehf. - simvastatinum inn - filmuhúðuð tafla - 40 mg
아이슬란드 -
아이슬란드어 -
LYFJASTOFNUN (Icelandic Medicines Agency)
simvastatin bluefish filmuhúðuð tafla 10 mg
bluefish pharmaceuticals ab - simvastatinum inn - filmuhúðuð tafla - 10 mg
아이슬란드 -
아이슬란드어 -
LYFJASTOFNUN (Icelandic Medicines Agency)
simvastatin bluefish filmuhúðuð tafla 20 mg
bluefish pharmaceuticals ab - simvastatinum inn - filmuhúðuð tafla - 20 mg
유럽 연합 -
아이슬란드어 -
EMA (European Medicines Agency)
litfulo
pfizer europe ma eeig - ritlecitinib tosilate - alopecia areata - Ónæmisbælandi lyf - litfulo is indicated for the treatment of severe alopecia areata in adults and adolescents 12 years of age and older.
아이슬란드 -
아이슬란드어 -
LYFJASTOFNUN (Icelandic Medicines Agency)
vibeden stungulyf, lausn 1 mg/ml
sandoz a/s* - hydroxocobalaminum hýdróklóríð - stungulyf, lausn - 1 mg/ml